Literature DB >> 14744250

The role of calpain in oncotic cell death.

Xiuli Liu1, Terry Van Vleet, Rick G Schnellmann.   

Abstract

Numerous lines of evidence demonstrate that calpains, a family of 14 Ca(2+)-activated neutral cysteine proteases, are involved in oncotic cell death in a variety of models. At this time, the biochemistry of most calpains and the specific roles of different calpains in physiology and pathology remain to be determined. A number of calpain substrates have been identified in cellular systems, including cytoskeletal proteins, and recent studies suggest that calpains mediate the increase in plasma membrane permeability to ions and the progressive breakdown of the plasma membrane observed in oncosis through the proteolysis of cystokeletal and plasma membrane proteins. Further, a number of reports provide evidence that the mitochondrial dysfunction observed in oncosis may be mediated by a mitochondrial calpain of unknown identity. Finally, a number of diverse calpain inhibitors have been developed that show cytoprotective properties in cellular systems and in vivo following diverse insults. It is suggested that future research be directed toward elucidation of the role(s) of specific calpain isozymes in physiological and pathological conditions; identifying and linking specific calpain substrates with altered cellular functions; and developing cell-permeable, potent, isozyme-selective calpain inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744250     DOI: 10.1146/annurev.pharmtox.44.101802.121804

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  58 in total

Review 1.  Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells.

Authors:  Susan L Fink; Brad T Cookson
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

Review 2.  Pharmacological manipulation of cell death: clinical applications in sight?

Authors:  Douglas R Green; Guido Kroemer
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Ali Karaouni; Sergei A Grando
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

Review 4.  Cell death in the nervous system.

Authors:  Dale E Bredesen; Rammohan V Rao; Patrick Mehlen
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

5.  Sustained calpain inhibition improves locomotor function and tissue sparing following contusive spinal cord injury.

Authors:  Chen-Guang Yu; James W Geddes
Journal:  Neurochem Res       Date:  2007-05-03       Impact factor: 3.996

6.  Evaluation of a continuous quantification method of apoptosis and necrosis in tissue cultures.

Authors:  Debby Gawlitta; Cees W J Oomens; Frank P T Baaijens; Carlijn V C Bouten
Journal:  Cytotechnology       Date:  2005-11-30       Impact factor: 2.058

7.  Regulation of proteolytic cleavage of retinoid X receptor-α by GSK-3β.

Authors:  Weiwei Gao; Jie Liu; Mengjie Hu; Mingfeng Huang; Sisi Cai; Zhiping Zeng; Bingzhen Lin; Xihua Cao; Jiebo Chen; Jin-zhang Zeng; Hu Zhou; Xiao-kun Zhang
Journal:  Carcinogenesis       Date:  2013-02-06       Impact factor: 4.944

8.  Calpain 10 is required for cell viability and is decreased in the aging kidney.

Authors:  Marisa D Covington; David D Arrington; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

Review 9.  Phytochemicals in Ischemic Stroke.

Authors:  Joonki Kim; David Yang-Wei Fann; Raymond Chee Seong Seet; Dong-Gyu Jo; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2016-05-18       Impact factor: 3.843

10.  Preapoptotic protease calpain-2 is frequently suppressed in adult T-cell leukemia.

Authors:  Makoto Ishihara; Natsumi Araya; Tomoo Sato; Ayako Tatsuguchi; Naomi Saichi; Atae Utsunomiya; Yusuke Nakamura; Hidewaki Nakagawa; Yoshihisa Yamano; Koji Ueda
Journal:  Blood       Date:  2013-03-28       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.